Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase

RJ Obaid, N Naeem, EU Mughal, MM Al-Rooqi… - RSC …, 2022 - pubs.rsc.org
Heterocycles are the key structures in organic chemistry owing to their immense applications
in the biological, chemical, and pharmaceutical fields. Heterocyclic compounds perform …

Tacrine derivatives in neurological disorders: Focus on molecular mechanisms and neurotherapeutic potential

S Mitra, M Muni, NJ Shawon, R Das… - Oxidative Medicine …, 2022 - Wiley Online Library
Tacrine is a drug used in the treatment of Alzheimer's disease as a cognitive enhancer and
inhibitor of the enzyme acetylcholinesterase (AChE). However, its clinical application has …

Merged tacrine-based, multitarget-directed acetylcholinesterase inhibitors 2015–present: Synthesis and biological activity

TJ Eckroat, DL Manross, SC Cowan - International journal of molecular …, 2020 - mdpi.com
Acetylcholinesterase is an important biochemical enzyme in that it controls acetylcholine-
mediated neuronal transmission in the central nervous system, contains a unique structure …

Synthesis, characterization, crystal structures, theoretical calculations and biological evaluations of novel substituted tacrine derivatives as cholinesterase and …

S Ökten, M Ekiz, ÜM Koçyiğit, A Tutar, İ Çelik… - Journal of Molecular …, 2019 - Elsevier
The six and seven hydrocycle membered disilylanilino acridine (tacrine) analogues (9–11)
were synthesized by one-pot procedures. The structures of novel silyl tacrine derivatives …

[HTML][HTML] SAR studies of quinoline and derivatives as potential treatments for Alzheimer's disease

ZH Li, LQ Yin, DH Zhao, LH Jin, YJ Sun… - Arabian Journal of …, 2023 - Elsevier
Quinoline analogs are an important class of N-based heterocyclic compounds, which have
received extensive attention because of their use in medicinal chemistry and organic …

A review on α-mangostin as a potential multi-target-directed ligand for Alzheimer's disease

A Yang, C Liu, J Wu, X Kou, R Shen - European Journal of Pharmacology, 2021 - Elsevier
Alzheimer's disease (AD) is an age-related neurodegenerative disease characterized by
progressive memory loss, declining language skills and other cognitive disorders. AD has …

Cu-metal organic frameworks (Cu-MOF) as an environment-friendly and economical catalyst for one pot synthesis of tacrine derivatives

H Mollabagher, S Taheri, M majid Mojtahedi… - RSC …, 2020 - pubs.rsc.org
The present work describes the catalytic activity of Cu-MOF for the one-pot synthesis of
tacrine derivatives via a four-component reaction of 2-hydroxynaphthalene-1, 4-dione …

A review on recent development of novel heterocycles as acetylcholinesterase inhibitor for the treatment of Alzheimer's disease

A Patel, D Shah, Y Patel, S Patel, M Mehta… - Current Drug …, 2023 - ingentaconnect.com
Alzheimer's Disease (AD), affecting a large population worldwide, is characterized by the old
population's loss of memory and learning ability. Cholinergic deficiency is associated with …

Novel AP2238-clorgiline hybrids as multi-target agents for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation

G Zhong, J Guo, C Pang, D Su, C Tang, L Jing… - Bioorganic …, 2023 - Elsevier
Cholinesterase and monoamine oxidase are potential targets for the therapy of Alzheimer's
disease. A series of novel AP2238-clorgiline hybrids as multi-target agents were designed …

Synthesis and activity towards Alzheimer's disease in vitro: Tacrine, phenolic acid and ligustrazine hybrids

G Li, G Hong, X Li, Y Zhang, Z Xu, L Mao… - European Journal of …, 2018 - Elsevier
A series of novel tacrine-phenolic acid dihybrids and tacrine-phenolic acid-ligustrazine
trihybrids were synthesized, characterized and screened as novel potential anti-Alzheimer …